Accelerating paediatric formulation development through smart design and predictive science

该项目是英国大型制药公司、学术界和技术供应商之间的合作，旨在生成一种结构化的方法来设计适合儿童年龄的药物和预测其质量和性能的技术。儿科医学目前是制药行业的一个“热门话题”，在开发儿童药物方面付出了很多努力，这些药物在口味上可以接受，但也为这些患者提供了所需的相关剂量和暴露量。该成果将为开发儿童药物提供一条更明智的途径，通过确定推动配方设计的最适当的检测策略，减少开发成本和时间。

This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot of effort going into developing such medicines for children that are acceptable in terms of taste but also provide the relevant dose and exposure required for such patients. The output will provide a smarter route to developing children’s medicines to reduce costs and time of development by determination of the most appropriate testing strategies that drive formulation design.